![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
Stanford University |
---|---|
Information provided by: | Stanford University |
ClinicalTrials.gov Identifier: | NCT00568360 |
Endoscopy is a standard part of the evaluation of patients with head and neck cancer used for determining the extent of tumor involvement. However, not all areas involved by tumor are apparent visually. Preliminary results indicate that compared with normal tissues, tumors have abnormal levels of capillary oxygenation. The purpose of this study is to determine the ability of non-pulsatile visible light tissue oxygen monitoring to differentiate normal and tumor tissue based on capillary oxygenation during endoscopy Should this be possible, this method could be used to mark tumor extent and invasion, even when that invasion is up to 5mm blow the tissue surface.
Condition | Intervention |
---|---|
Head and Neck Cancer |
Device: Oximeter |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:All patients with newly diagnosed head and neck cancer as well as those being seen for routine follow up with no evidence of current disease and healthy volunteers are eligible for this study.
United States, California | |
Stanford University School of Medicine | Recruiting |
Stanford, California, United States, 94305 | |
Contact: Peter Maxim, MD 650-724-3018 peter.maxim@stanford.edu | |
Contact: Cancer Clinical Trials Office (650) 498-7061 | |
Principal Investigator: Peter Maxim PhD | |
Sub-Investigator: Dr. Billy W. Loo Jr. M.D. Ph.D. | |
Sub-Investigator: Quynh-Thu Le | |
Sub-Investigator: Dr Ranjiv Sivanandan | |
Sub-Investigator: Lei Xing |
Principal Investigator: | Peter Maxim PhD | Stanford University |
Study ID Numbers: | SU-11062007-817, 79938, ENT0014, NCT00568360 |
Study First Received: | December 4, 2007 |
Last Updated: | November 26, 2008 |
ClinicalTrials.gov Identifier: | NCT00568360 History of Changes |
Health Authority: | United States: Food and Drug Administration; United States: Institutional Review Board |
Head and Neck Neoplasms |
Neoplasms Neoplasms by Site Head and Neck Neoplasms |